Rikuya Okui Selected Research

JNJ 10397049

1/2019

Activation of orexinergic and histaminergic pathway involved in therapeutic effect of histamine H4 receptor antagonist against cisplatin-induced anorexia in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rikuya Okui Research Topics

Disease

2	Anorexia 01/2019 - 01/2018
1	Hypothalamic Neoplasms 01/2019
1	Necrosis 01/2019
1	Neoplasms (Cancer) 01/2018
1	Vomiting 01/2018
1	Nausea 01/2018

Drug/Important Bio-Agent (IBA)

2	Histamine H4 ReceptorsIBA 01/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 01/2018
2	1- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA 01/2019 - 01/2018
1	Orexin ReceptorsIBA 01/2019
1	JNJ 10397049IBA 01/2019
1	SB 408124IBA 01/2019
1	OrexinsIBA 01/2019
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	ciproxifanIBA 01/2019
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	CytokinesIBA 01/2018
1	AntiemeticsIBA 01/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018
1	Granisetron (Kytril)FDA LinkGeneric 01/2018

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2018